Patents by Inventor Hadi Danaee

Hadi Danaee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ASSESSMENT OF CHROMOSOMAL ALTERATIONS TO PREDICT CLINICAL OUTCOME OF BORTEZOMIB TREATMENT
    Publication number: 20160312309
    Abstract: Disclosed herein are chromosomal loci associated with clinical outcome to treatment for multiple myeloma. Genome-wide changes observed in myeloma relate to prognosis and treatment response to a proteasome inhibitor. Compositions and methods are provided to assess DNA copy number at corresponding to markers of loci and genes found thereon which are amplified or deleted, overexpressed or underexpressed in myeloma tumors to predict response to treatment, time-to-progression and survival upon treatment.
    Type: Application
    Filed: July 8, 2016
    Publication date: October 27, 2016
    Inventors: Barbara M. Bryant, Hadi Danaee, George J. Mulligan
  • Assessment of chromosomal alterations to predict clinical outcome of bortezomib treatment
    Publication number: 20100086922
    Abstract: Disclosed herein are chromosomal loci associated with clinical outcome to treatment for multiple myeloma. Genome-wide changes observed in myeloma relate to prognosis and treatment response to a proteasome inhibitor. Compositions and methods are provided to assess DNA copy number at corresponding to markers of loci and genes found thereon which are amplified or deleted, overexpressed or underexpressed in myeloma tumors to predict response to treatment, time-to-progression and survival upon treatment.
    Type: Application
    Filed: May 27, 2009
    Publication date: April 8, 2010
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Barbara M. Bryant, Hadi Danaee, George J. Mulligan